ACSS2 and cancer: The elevation of lipogenic enzymes, including ATP-citrate lyase (ACLY) and acetyl-CoA synthetase 2 (ACSS2), resulted in increased fatty acid synthesis and is often associated with poorer prognosis in cancer patients [27,28].